Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;17(6):1569-1570.
doi: 10.1007/s11739-022-02957-3. Epub 2022 Mar 17.

Use of antibiotics in respiratory viral infections

José Vicente Fernández-Montero  1 , Octavio Corral  2 , Pablo Barreiro  3 , Vicente Soriano  4
Affiliations
Comment

Use of antibiotics in respiratory viral infections

José Vicente Fernández-Montero et al. Intern Emerg Med. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors acknowledge no conflicts of interest relevant to this article.

Comment on

  • Bacterial infections in patients hospitalized with COVID-19.
    Moreno-Torres V, de Mendoza C, de la Fuente S, Sánchez E, Martínez-Urbistondo M, Herráiz J, Gutiérrez A, Gutiérrez Á, Hernández C, Callejas A, Maínez C, Royuela A, Cuervas-Mons V; Puerta de Hierro COVID-19 working group. Moreno-Torres V, et al. Intern Emerg Med. 2022 Mar;17(2):431-438. doi: 10.1007/s11739-021-02824-7. Epub 2021 Aug 18. Intern Emerg Med. 2022. PMID: 34406633 Free PMC article.

References

    1. Moreno-Torres V, de Mendoza C, de la Fuente S et al (2021) Bacterial infections in patients hospitalized with COVID-19. Intern Emerg Med. 10.1007/s11739-021-02824-7 - PMC - PubMed
    1. Griffin D, Brennan-Rieder D, Ngo B, et al. The importance of understanding the stages of COVID-19 in treatment and trials. AIDS Rev. 2021;23:40–47. doi: 10.24875/AIDSRev.200001261. - DOI - PubMed
    1. WHO Solidarity Trial Consortium Repurposed antiviral drugs for COVID-19 - interim WHO Solidarity trial results. N Engl J Med. 2021;384:497–511. doi: 10.1056/NEJMoa2023184. - DOI - PMC - PubMed
    1. Clancy C, Hong NM. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis. 2020;71:2736–2743. doi: 10.1093/cid/ciaa524. - DOI - PMC - PubMed
    1. Falcone M, Tiseo G, Giordano C, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76:1078–1084. doi: 10.1093/jac/dkaa530. - DOI - PMC - PubMed

MeSH terms

Substances